AIMZ Investment Advisors LLC Has $2.51 Million Holdings in Dolby Laboratories, Inc. (NYSE:DLB)

AIMZ Investment Advisors LLC decreased its position in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,165 shares of the electronics maker’s stock after selling 298 shares during the quarter. AIMZ Investment Advisors LLC’s holdings in Dolby Laboratories were worth $2,512,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Creative Planning boosted its stake in Dolby Laboratories by 7.5% during the 3rd quarter. Creative Planning now owns 4,094 shares of the electronics maker’s stock valued at $313,000 after purchasing an additional 286 shares during the last quarter. International Assets Investment Management LLC purchased a new position in shares of Dolby Laboratories during the third quarter valued at approximately $3,895,000. Wealth Enhancement Advisory Services LLC grew its holdings in Dolby Laboratories by 37.9% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 5,326 shares of the electronics maker’s stock worth $408,000 after buying an additional 1,465 shares in the last quarter. State of Alaska Department of Revenue raised its position in Dolby Laboratories by 143.6% in the 3rd quarter. State of Alaska Department of Revenue now owns 27,937 shares of the electronics maker’s stock valued at $2,137,000 after buying an additional 16,470 shares during the last quarter. Finally, Cambiar Investors LLC lifted its stake in Dolby Laboratories by 0.7% during the 3rd quarter. Cambiar Investors LLC now owns 137,000 shares of the electronics maker’s stock valued at $10,485,000 after acquiring an additional 905 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on DLB. Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday, January 30th. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Thursday, February 13th. Finally, StockNews.com cut shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday, January 31st.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $81.03 on Friday. The company has a market capitalization of $7.73 billion, a PE ratio of 29.79 and a beta of 0.98. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66. The business has a fifty day moving average price of $80.90 and a two-hundred day moving average price of $76.61.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were issued a dividend of $0.33 per share. The ex-dividend date of this dividend was Tuesday, February 11th. This represents a $1.32 dividend on an annualized basis and a yield of 1.63%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.53%.

Insiders Place Their Bets

In other news, EVP Mark Andrew Sherman sold 12,338 shares of the stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $78.08, for a total transaction of $963,351.04. Following the completion of the transaction, the executive vice president now owns 62,397 shares in the company, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $84.07, for a total value of $588,490.00. Following the completion of the sale, the chief accounting officer now directly owns 29,758 shares of the company’s stock, valued at approximately $2,501,755.06. This trade represents a 19.04 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 77,459 shares of company stock valued at $6,464,675. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.